Xconomy

JULY 2, 2020

San Diego-based MEI (NASDAQ: MEIP ), licensed the compound, pracinostat, from a Singaporean biotech company in 2013.

San Diego 86

San Diego Study Help Company 86

Xconomy

MARCH 28, 2018

A healthtech startup founded by two doctors who set out in 2013 to improve the overall management of their respective medical practices is emerging from beta mode Wednesday to offer fellow physicians an office software suite. See below. ]

Software 66

Software Social Media San Diego SaaS 66

Xconomy

JANUARY 4, 2017

Craig Venter, who disclosed last month he’s being treated for prostate cancer , is moving into a new role as executive chairman at Human Longevity (HLI), the San Diego genomics startup he co-founded in 2013. Before joining GE Healthcare in 2013, Collins was CEO at Genvec, a group.

San Diego 59

San Diego Startup Blogging 59

Xconomy

JANUARY 26, 2018

Genomatica, a San Diego industrial biotech, has spent the past 12 years or more working to take the petroleum part out of the petrochemical industry. Since 2013, it’s been kind of a roller coaster,” Genomatica. In 2008, for example, Genomatica showed it had bio-engineered E.

San Diego 59

San Diego Examples Technology Blogging 59

Xconomy

APRIL 25, 2019

Katelyn O’Shaughnessy already had a solid track record, selling TripScope , a travel startup she co-founded in 2013, to Travefy two years ago. Women, finding themselves outside of the club, are now creating their own networks to do the same.

Help 111

Help Startup Networking Ideas 111

Xconomy

AUGUST 1, 2016

PacketSled, a cybersecurity startup based in suburban San Diego, has raised $5 million in a Series A funding round led by Keshif Ventures, a local angel investment fund that has put money into dozens of tech startups in the San Diego area. The company raised $3 million in a 2013 seed round.

San Diego 40

San Diego Conference Funding Networking 40

Xconomy

AUGUST 10, 2016

On the day after Intel announced its acquisition of San Diego machine learning startup Nervana Systems, investor Steve Jurvetson told me he was feeling a sense of satisfaction about a call he made three years ago, and how it has been playing out.

Artificial Inteligence 40

Artificial Inteligence San Diego Framework Venture Capital 40

Xconomy

SEPTEMBER 26, 2016

Tealium, a San-Diego startup that provides online advertising tag management and marketing services for enterprise customers, has raised $35 million in a growth financing deal intended to expand its technology and market reach. The company’s workforce has grown to about 270, including 80 in San Diego.

Customer 40

Customer Custom San Diego JavaScript 40

Xconomy

DECEMBER 7, 2018

Founded in 2013 by de Haaff and Chris Waters in the Bay Area, the company announced in July it had surpassed $40 million in annual recurring revenue from the subscribers to its software-as-a-service. Brian de Haaff wonders this sometimes, especially as compared to his own tech business, Aha. Instead, Aha is a bootstrapped startup.

Sales 100

Sales Software Services Startup 100

Xconomy

OCTOBER 6, 2016

Headed by the computational neuroscientist Eugene Izhikevich, the company maintained a low profile at Qualcomm’s San Diego headquarters until 2013, when Brain Corp. The company actually has been test-driving its technology on floor scrubbers used to clean Jimbo’s, a San Diego natural foods grocer. “We

Product 106

Product Artificial Inteligence San Diego Training 106

Xconomy

JULY 12, 2016

— 5D Robotics , founded in 2009 in Carlsbad, CA, (about 30 miles north of San Diego), has developed a device that integrates GPS, inertial guidance, optical positioning, and other technologies. SlantRange, a San Diego company founded almost three years ago, is a drone-related startup already generating sales.

San Diego 40

San Diego Seed Funding Guide Technology 40

Xconomy

NOVEMBER 6, 2019

But in 2013, the Anglo-Swedish Big Pharma firm exited the site as part of a restructuring that moved its global R&D center and corporate headquarters to Cambridge, UK. Public-private partnership and science park.

Sites 75

Sites Startup Research Develop 75

Xconomy

JANUARY 7, 2020

Rob Williamson, a longtime biotech entrepreneur, joined PharmAkea as CEO in 2013 after the company formed its “build-to-buy”-style. But the partnership fizzled, and this week PharmAkea sold the last of the two drug candidates it developed for fibrotic disease to Galecto, a clinical-stage biotech in Denmark. Financial terms weren’t disclosed.

Seed Funding 63

Seed Funding Equity Research Acquisition 63

Xconomy

JUNE 13, 2019

The new Series B round will give San Francisco-based BlackThorn—a startup spun out of the Scripps Research Institute in 2013—the backing to run human tests of two experimental treatments. One, headed for Phase 2 testing by next year, is being developed for mood or anxiety disorders.

Tool 78

Tool Study Research Startup 78

Xconomy

JULY 27, 2016

LabCorp will also assume net debt of San Diego-based Sequenom (NASDAQ: SQNM ), bringing the value of the cash deal to approximately $371 million. In 2013, when Sequenom reported a $107.4 In 2014, Sequenom sold a genetic analysis tool and a bioscience facility to San Diego-based Agena Bioscience for $31.8

San Diego 40

San Diego .Net Report Sites 40

Xconomy

DECEMBER 5, 2018

Those amounts, siphoned away during the period between December 2007 and September 2013, were not owed to him, according to a Department of Justice account. He was accused of diverting more than $18 million from the $283 million Burrill Life Sciences Capital Fund III under the guise of management fees. Burrill was also charged.

Venture Capital 70

Venture Capital Conference Funding Invest 70

Xconomy

JUNE 23, 2016

Without the aid of venture capital , the small upstart says, it has grown to “tens of thousands” of customers in five metro areas: the Bay Area, Boston, Chicago, Miami, and San Diego. Barr wrote in a blog post announcing the tie-up. Now, Webpass will tap into those deep pockets. “By

Google 45

Google San Diego Resource Blogging 45

Xconomy

SEPTEMBER 2, 2016

Nobel Prize winner Roger Tsien, a UC San Diego chemist, passed away in Oregon this week. As the San Diego Union Tribune reported in 2013, Tsien (pictured) was also unafraid to shine the spotlight on what he considered suspect scientific approaches, even when espoused by legends like DNA co-discoverer James Watson. .

News 57

News San Diego Journal Technical Review 57

Xconomy

SEPTEMBER 11, 2019

GlaxoSmithKline is acquiring a startup it helped launch in 2013 as part of an alliance with life sciences venture capital firm Avalon Ventures. Avalon said Tuesday that GSK (NYSE: GSK ) has agreed to buy the company, Sitari Pharmaceuticals, which has been developing a treatment for celiac disease.

Avalon 56

Avalon Invest Southern California Develop 56

Xconomy

JULY 21, 2017

Adam Riggs-Zeigen has come a long way since 2013, when he co-founded San Diego’s Rock My World and introduced the mobile app RockMyRun to provide upbeat music playlists to motivate smartphone-equipped runners. “We We found that it expanded into other avenues, like fitness studios,” Riggs-Zeigen recalled in a recent interview.

Mobile 79

Mobile Software Startup Web 2.0 79

Xconomy

OCTOBER 3, 2016

Morris did go on to co-found an aerial imagery company for agriculture in 2013, but he scrapped the idea of using drones. Companies such as San Diego-based SlantRange are betting that drones, flying lower and slower, can deliver images at higher resolution than either planes or satellites.

San Diego 107

San Diego Outsource Development Startup Resource 107

Xconomy

MAY 31, 2016

If that sounds familiar, it’s because the Redmond, WA, technology giant combined several of its startup-focused projects—including an earlier investment vehicle, the Bing Fund—under that name in 2013.

Funding 62

Funding Artificial Inteligence Cloud Computing Writing 62

Xconomy

AUGUST 8, 2016

The deal for pracinostat represents a comeback of sorts for MEI Pharma and a redemption for CEO Daniel Gold, who joined MEI when the company moved to San Diego from Australia in 2010. Under Gold, MEI licensed pracinostat in 2013 from a Singaporean biotech company that was liquidating its assets.

Study 40

Study San Diego News Design 40

Xconomy

OCTOBER 16, 2016

After raising $30 million, San Diego-based Certona said it is moving to accelerate its product development, expand its sales and marketing team, and improve its client services as an e-commerce technology vendor. billion.

Artificial Inteligence 40

Artificial Inteligence Commerce San Diego Web 40

Xconomy

JANUARY 27, 2017

The IPO is a big haul for Jounce, reminiscent of biotech’s bull run from 2013 to 2015 , Read more » Reprints | Share: Jounce also priced above the $13 to $15 per share range it had set. It will start trading on the Nasdaq this morning under the symbol “JNCE.”

Pricing 40

Pricing San Diego Company Companies 40

Xconomy

OCTOBER 17, 2016

Daniel is now the founding executive director of what he calls a “shell” advisory group in San Diego named Catalysis Advisors, from which he’s advising some biotechs and venture firms and acting as a “founding consultant” to other startups. I’m still in the game,” Daniel says, “just trying to create a bit of a different role.”.

Course 40

Course San Diego Template Startup 40

Xconomy

JULY 21, 2016

He also benefited from a program already in place, an oral multiple sclerosis drug called dimethyl fumarate (Tecfidera) that went on to win FDA approval in 2013 and become a blockbuster drug. Biogen was in a long-running battle with Carl Icahn about its strategic direction and hadn’t produced any FDA approved drugs in six years.

San Diego 40

San Diego Conference Pricing Acquisition 40

Xconomy

OCTOBER 20, 2016

As Xconomy reported last year, South San Francisco, CA-based BlackThorn was spun out of Scripps Research Institute , which on its website lists the company as one of its 2013 spinouts. Today, BlackThorn is making its first formal announcement.

Research 40

Research Study Press Equity 40

Xconomy

SEPTEMBER 23, 2016

As a tool for diagnosing rheumatoid arthritis and other autoimmune diseases, Ignyta’s technology failed in early 2013, Lim said in a recent interview. Instead, Lim may end up showing how to breathe new life into a life sciences company that was flat-lining, at least in terms of developing new technology.

Study 40

Study Tool Technology Capital 40

Xconomy

JULY 20, 2016

NASDAQ: AGTC ), AveXis (NASDAQ: AVXS ) and others have all gone public since 2013. Here’s more on Audentes shortly after its Series A round in 2013. Bluebird, Spark, UniQure (NASDAQ: QURE ), Dimension Therapeutics (NASDAQ: DMTX ), RegenXBio (NASDAQ: RGNX ), Voyager Therapeutics (NASDAQ: VYGR ), Applied Genetic Technologies Corp.

Pricing 40

Pricing Equity Marketing Tool 40

Xconomy

OCTOBER 18, 2016

Called sofosbuvir (Sovaldi), the drug won FDA approval in December 2013. Telaprevir’s sales cratered, and Vertex axed 15 percent of its workforce in October 2013. With evidence of up to 90 percent cure rates in three months and a very clean safety profile, sofosbuvir quickly made telaprevir obsolete.

Startup 40

Startup Research Sales Organization 40

Xconomy

JULY 18, 2016

In 2012, then-Research Triangle Park, NC-based Tranzyme Pharma, which was acquired by Ocera Therapeutics (NASDAQ: OCRX ) in a reverse merger in 2013, stopped work on its experimental treatment for the condition after the company’s pill was outperformed by a placebo in a mid-stage clinical trial.

Study 40

Study Sites News Research 40

Xconomy

OCTOBER 25, 2016

million this year versus $3 million in 2013. Editor’s note: A longer version of this post originally appeared on Greeley’s blog, “On the Flying Bridge.” ]. For instance, early-stage round sizes are tracking to be nearly $5.5 Reprints | Share: UNDERWRITERS AND PARTNERS.

Venture Capital 40

Venture Capital Capital Activity Invest 40

Xconomy

OCTOBER 27, 2016

The increase in dollars flowing to agtech comes despite commodity prices that are down 65 percent from their 2013 peak, the report says. They also queried 15 VC firms.

Venture Capital 40

Venture Capital Pricing Invest Report 40

Xconomy

AUGUST 12, 2016

Celgene paid Acetylon $100 million in 2013 for an option to buy the company outright, but the deal recently expired without an acquisition, leaving Acetylon to chart a new course. . —Option-to-buy deals are by definition no guarantee, and an agreement between Boston-based Acetylon Pharmaceuticals and Celgene is the latest example.

Google 40

Google Technical Review News Research 40

Xconomy

JUNE 3, 2016

A 2013 New Jersey tax notice says that several types of services that are delivered using a computing platform are subject to tax as an information service. New York said that the company is providing taxable cloud computing services. If the same service was provided by a traveling nurse, it would not be subject to New York sales tax.

Sales 62

Sales Company Companies Software Review 62

Xconomy

NOVEMBER 1, 2016

(The most recent CMS data are for 2014, when the Government Accountability Office issued a report on the surge of Medicare spending from medications approved between 2006 and 2013.). They block a protein called VEGF and stop abnormal blood vessels from forming.

Pricing 40

Pricing Press Services Report 40